The nanny states ride again. Thanks for clearing that up Mate! Very happy with the US market at what 15 to 30% in Males and 10 to 15% in females with sleep apnea. Super exciting if patients where given a prescription for IHL-43X along with a usual C-PAP brochure, with the later only being strapped on if they don't see AHI reduction from IHL43X. First line SOC sounds good to me.
Everything pointing to the FDA giving the green light for a pivotal trial. If granted, will this Mean it skips a full phase II and strait into a final phase II / III trial?
The presentation announcement is a very good read. This management is second to none!
The nanny states ride again. Thanks for clearing that up Mate!...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)